DCALBSEDishman Carbogen Amcis LtdMediumNeutral
Announced Sun, 15 Mar · 12:38 IST

Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/03/2026 ,inter alia, to consider and approve The Proposal Of Fund ....

Fund Raising View source PDF

DCAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹161.80
prior close
₹159.01
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.4+1.6+4.7+1.2+5.7-0.6-1.9-11.6-4.8-2.3+5.1+16.8+9.6
Up moveDown movePending
AI summary

Dishman Carbogen Amcis has informed the stock exchanges that its Board of Directors will meet on 18th March 2026. The main agenda item is to consider and approve a proposal for raising funds through the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. The decision is subject to necessary regulatory and statutory approvals. The intimation was filed on 14th March 2026 by Company Secretary Shrima Dave. No specific issue size, coupon rate, or tenor has been disclosed at this stage.

Likely market impact

This is a pre-announcement of a potential debt raise via NCDs. Existing shareholders are not being diluted since NCDs are debt instruments, not equity. The stock price impact is likely to be neutral unless the NCD terms (size, interest rate) suggest stress on the company's cash flows or balance sheet.